- Home
- OPTT vs STRO Comparison
OPTT vs STRO Comparison
Compare OPTT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPTT | STRO |
|---|---|---|
| Founded | 1984 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 85.0M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OPTT | STRO |
|---|---|---|
| Price | $0.34 | $11.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 8 |
| Target Price | $1.50 | ★ $18.29 |
| AVG Volume (30 Days) | ★ 3.7M | 125.6K |
| Earning Date | 12-15-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,748,000.00 | ★ $105,646,000.00 |
| Revenue This Year | $70.98 | $63.08 |
| Revenue Next Year | $106.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.30 | $5.23 |
| 52 Week High | $1.75 | $21.50 |
Technical Indicators
Market Signals| Indicator | OPTT | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 82.73 |
| Support Level | $0.30 | $8.49 |
| Resistance Level | $0.38 | $11.09 |
| Average True Range (ATR) | 0.03 | 0.87 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 27.61 | 83.01 |
Price Performance
Historical ComparisonAbout OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.